{"id":"https://openalex.org/W2002005804","doi":"https://doi.org/10.1186/1471-2407-14-599","title":"Variable NF-\u03baB pathway responses in colon cancer cells treated with chemotherapeutic drugs","display_name":"Variable NF-\u03baB pathway responses in colon cancer cells treated with chemotherapeutic drugs","publication_year":2014,"publication_date":"2014-08-18","ids":{"openalex":"https://openalex.org/W2002005804","doi":"https://doi.org/10.1186/1471-2407-14-599","mag":"2002005804","pmid":"https://pubmed.ncbi.nlm.nih.gov/25134433","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4152571"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2407-14-599","doi":"https://doi.org/10.1186/1471-2407-14-599","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-14-599","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-14-599","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-14-599","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110514819","display_name":"Temesgen Samuel","orcid":"https://orcid.org/0000-0001-9722-5318","observed_orcids":["https://orcid.org/0000-0001-9722-5318"]},"institutions":[{"id":"https://openalex.org/I6026837","display_name":"Tuskegee University","ror":"https://ror.org/0137n4m74","country_code":"US","type":"education","lineage":["https://openalex.org/I6026837"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Temesgen Samuel","raw_affiliation_strings":["School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA. tsamuel@mytu.tuskegee.edu","School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA. tsamuel@mytu.tuskegee.edu","institution_ids":["https://openalex.org/I6026837"]},{"raw_affiliation_string":"School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, USA","institution_ids":["https://openalex.org/I6026837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035009498","display_name":"Khalda Fadlalla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6026837","display_name":"Tuskegee University","ror":"https://ror.org/0137n4m74","country_code":"US","type":"education","lineage":["https://openalex.org/I6026837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khalda Fadlalla","raw_affiliation_strings":["School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, AL, 36088, USA","School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, AL, 36088, USA","institution_ids":["https://openalex.org/I6026837"]},{"raw_affiliation_string":"School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, USA","institution_ids":["https://openalex.org/I6026837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085267242","display_name":"Dominique N. Gales","orcid":"https://orcid.org/0000-0003-4335-2519","observed_orcids":["https://orcid.org/0000-0003-4335-2519"]},"institutions":[{"id":"https://openalex.org/I6026837","display_name":"Tuskegee University","ror":"https://ror.org/0137n4m74","country_code":"US","type":"education","lineage":["https://openalex.org/I6026837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominique N Gales","raw_affiliation_strings":["School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, AL, 36088, USA","School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, AL, 36088, USA","institution_ids":["https://openalex.org/I6026837"]},{"raw_affiliation_string":"School of Veterinary Medicine, Pathobiology Department and TU Center for Cancer Research, Tuskegee University, Tuskegee, USA","institution_ids":["https://openalex.org/I6026837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108261932","display_name":"Balananda D. Kumar Putcha","orcid":"https://orcid.org/0009-0007-0111-8245","observed_orcids":["https://orcid.org/0009-0007-0111-8245"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Balananda DK Putcha","raw_affiliation_strings":["Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA","Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038817160","display_name":"Upender Manne","orcid":"https://orcid.org/0000-0002-1545-3032","observed_orcids":["https://orcid.org/0000-0002-1545-3032"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4390039250","display_name":"UAB Medicine","ror":"https://ror.org/036554539","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039250"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Upender Manne","raw_affiliation_strings":["Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA","Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Department of Pathology and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA","institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4390039250"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5110514819"],"corresponding_institution_ids":["https://openalex.org/I6026837"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":1.2807,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.77006968,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"14","issue":"1","first_page":"599","last_page":"599"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9639999866485596},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9629999995231628},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.925000011920929},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.6489999890327454},{"id":"https://openalex.org/keywords/cxcr2","display_name":"CXCR2","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ciap2","display_name":"cIAP2","score":0.9300000071525574},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6209999918937683},{"id":"https://openalex.org/keywords/paracrine-signaling","display_name":"paracrine signaling","score":0.8539999723434448},{"id":"https://openalex.org/keywords/nf-kappab-inhibitors","display_name":"NF-\u03baB inhibitors","score":0.609000027179718},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.859000027179718},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.8349999785423279},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5978617072105408},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4592215418815613},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.4337945580482483},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.42620497941970825},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3877650499343872},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3303043246269226},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26555541157722473},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2315351665019989},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07621368765830994},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010692","descriptor_name":"Phleomycins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010692","descriptor_name":"Phleomycins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045325","descriptor_name":"HCT116 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/1471-2407-14-599","doi":"https://doi.org/10.1186/1471-2407-14-599","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-14-599","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-14-599","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3122840","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4152571","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4152571","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4152571","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmid:25134433","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25134433","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1186/1471-2407-14-599","doi":"https://doi.org/10.1186/1471-2407-14-599","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-14-599","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-14-599","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2247584518","display_name":"Quercetin as an enhancer of the efficacy of 5-FU in mouse models of colon cancer","funder_award_id":"SC3GM109314","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G503768248","display_name":"CENTER FOR BIOMEDICAL RESEARCH","funder_award_id":"G12MD007585","funder_id":"https://openalex.org/F4320337534","funder_display_name":"National Institute on Minority Health and Health Disparities"},{"id":"https://openalex.org/G9000862540","display_name":"2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership","funder_award_id":"U54CA118623","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000882333","display_name":"1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership","funder_award_id":"U54CA118638","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000884756","display_name":"3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership","funder_award_id":"U54CA118948","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337534","display_name":"National Institute on Minority Health and Health Disparities","ror":"https://ror.org/0493hgw16"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2002005804.pdf","grobid_xml":"https://content.openalex.org/works/W2002005804.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1260746200","https://openalex.org/W1481925502","https://openalex.org/W1952574243","https://openalex.org/W1965384908","https://openalex.org/W1969309856","https://openalex.org/W1979448695","https://openalex.org/W1982013021","https://openalex.org/W1982814560","https://openalex.org/W1983398917","https://openalex.org/W1984292032","https://openalex.org/W1989654707","https://openalex.org/W1991221096","https://openalex.org/W1995143704","https://openalex.org/W2000821407","https://openalex.org/W2020098501","https://openalex.org/W2046270184","https://openalex.org/W2051782642","https://openalex.org/W2055579579","https://openalex.org/W2057337576","https://openalex.org/W2059976465","https://openalex.org/W2062069198","https://openalex.org/W2074177924","https://openalex.org/W2080783895","https://openalex.org/W2090037913","https://openalex.org/W2091544698","https://openalex.org/W2097733438","https://openalex.org/W2100603815","https://openalex.org/W2101049648","https://openalex.org/W2103196126","https://openalex.org/W2103367814","https://openalex.org/W2103594050","https://openalex.org/W2107552318","https://openalex.org/W2111124916","https://openalex.org/W2121296674","https://openalex.org/W2123173724","https://openalex.org/W2124076790","https://openalex.org/W2134887638","https://openalex.org/W2138934663","https://openalex.org/W2143204311","https://openalex.org/W2143428408","https://openalex.org/W2157503717","https://openalex.org/W2161109457","https://openalex.org/W2315613727","https://openalex.org/W2783677708"],"related_works":["https://openalex.org/W2089508940","https://openalex.org/W7135339153","https://openalex.org/W2087973500","https://openalex.org/W2080070482","https://openalex.org/W2886734972","https://openalex.org/W2055878807","https://openalex.org/W2088633231","https://openalex.org/W2489799127","https://openalex.org/W2432402285","https://openalex.org/W2112424380"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,92,248],"nuclear":[2],"factor":[3],"kappa-light-chain-enhancer":[4],"of":[5,94,108,140,191,199,210,218],"activated":[6,13,154],"B":[7],"cells":[8,15,69,134,160,169,212,284,303],"(NF-\u03baB)":[9],"signaling":[10,33],"pathway":[11],"is":[12,34],"in":[14,28,40,62,123,156,161,167,216,227,252,285],"exposed":[16],"to":[17,36,42,137,254],"various":[18],"stimuli,":[19,44],"including":[20],"those":[21],"originating":[22],"on":[23,301],"the":[24,29,51,192,200,207,262,306],"cell":[25,38,151],"surface":[26],"or":[27,88,126,174,204],"nucleus.":[30],"Activated":[31],"NF-\u03baB":[32,61,67,95,109,155,183,233,245,258,269],"thought":[35],"enhance":[37],"survival":[39],"response":[41,253],"these":[43,144],"which":[45,56],"include":[46],"chemotherapy":[47],"and":[48,72,105,112,121,143,266],"radiation.":[49],"In":[50,178,230],"present":[52],"effort,":[53],"we":[54],"determined":[55],"anticancer":[57],"drugs":[58],"preferentially":[59],"activate":[60],"colon":[63,158,180],"cancer":[64,133,159,181,255,283],"cells.":[65],"METHODS:":[66],"reporter":[68,234],"were":[70,114,171],"established":[71],"treated":[73],"with":[74,213,261],"5-fluorouracil":[75],"(5-FU,":[76],"DNA/RNA":[77],"damaging),":[78,81],"oxaliplatin":[79],"(DNA":[80],"camptothecin":[82],"(CTP,":[83],"topoisomerase":[84],"inhibitor),":[85],"phleomycin":[86],"(radiomimetic),":[87],"erlotinib":[89],"(EGFR":[90],"inhibitor).":[91],"activation":[93,110,184,259,270],"was":[96,187,240],"assessed":[97],"by":[98,116,118,127,185,189,197,242],"immunofluorescence":[99],"for":[100,176,222,279],"p65":[101],"translocation,":[102],"luciferase":[103],"assays,":[104],"downstream":[106],"targets":[107],"(cIAP2,":[111],"Bcl-XL)":[113],"evaluated":[115],"immunoblotting,":[117],"ELISA":[119],"(CXCL8":[120],"IL-6":[122],"culture":[124],"supernatants),":[125],"gene":[128],"expression":[129],"analysis.":[130],"RESULTS:":[131],"Colon":[132],"responded":[135],"variably":[136],"different":[138,150],"classes":[139],"therapeutic":[141,256,292],"agents,":[142,257],"agents":[145],"initiated":[146],"variable":[147],"responses":[148],"among":[149],"types.":[152],"CPT":[153,186,214],"SW480":[157,179,231],"a":[162,220,286],"dose-dependent":[163],"manner,":[164],"but":[165,195,236],"not":[166,196,237],"HCT116":[168,211],"that":[170,267,297,304],"either":[172],"wild-type":[173],"deficient":[175],"p53.":[177],"cells,":[182,232],"accompanied":[188],"secretion":[190],"cytokine":[193,228,238],"CXCL8,":[194,223],"up-regulation":[198,217],"anti-apoptotic":[201,276],"genes,":[202],"cIAP2":[203],"Bcl-XL.":[205],"On":[206],"contrary,":[208],"treatment":[209],"resulted":[215],"CXCR2,":[219],"receptor":[221],"without":[224],"an":[225,244],"increase":[226],"levels.":[229],"activity,":[235],"secretion,":[239],"inhibited":[241],"SM-7368,":[243],"inhibitor.":[246],"CONCLUSION:":[247],"results":[249],"show":[250],"that,":[251],"varies":[260],"cellular":[263],"make":[264],"up":[265],"drug-induced":[268],"may":[271],"be":[272],"functionally":[273],"uncoupled":[274],"from":[275],"outcomes":[277],"found":[278],"other":[280],"stimuli.":[281],"Some":[282],"heterogeneous":[287],"tumor":[288],"tissue":[289],"may,":[290],"under":[291],"pressure,":[293],"release":[294],"soluble":[295],"factors":[296],"have":[298],"paracrine":[299],"activity":[300],"neighboring":[302],"express":[305],"cognate":[307],"receptors.":[308]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
